Autologous PBSCT in patients with cardiac amyloidosis [2]

Bone Marrow Transplantation

Volumn 26, Issue 5, 2000, Pages 588-589

  Stevens, J M ^a   Patton, W N ^a   Heaton, D C ^a   Spearing, R L ^a   Shaw, G ^a   Bowie, D ^a   Smyth, D ^a   Comenzo, R ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMYLOID; BENCE JONES PROTEIN; DIMETHYL SULFOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; MIDAZOLAM; MORPHINE;

ADULT; AUTOTRANSPLANTATION; BLOOD STORAGE; CARDIOGENIC SHOCK; CASE REPORT; CLINICAL FEATURE; CRYOPRESERVATION; DOSE RESPONSE; ECHOCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE BIOPSY; HEMATOPOIESIS; HEPATOMEGALY; HUMAN; HYDRATION; LETTER; LEUKAPHERESIS; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0033824518     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702551     Document Type: Letter

References (4)

1. Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report
2. Renal disease and protein binding of melphalan in patients with cancer
3. Pharmacokinetics of melphalan in children following high-dose intravenous injection
4. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplants